Results from a small Australian study provide new evidence that the immune systems of myeloma patients may play an important role in why some patients survive much longer than others.

In particular, the Australian researchers found that myeloma patients who live for more than 10 years after diagnosis have more robust immune function as compared to other myeloma patients.

Certain killer immune cells were more common, and divided more read­i­ly, in long-term myeloma survivors than in patients with shorter sur­vival.

The investigators also found that long-term survivors had more helper cells (which promote …

In a recent multi-center study, Spanish researchers identified several immune system characteristics of multiple myeloma patients who have achieved long-term disease control.

They found that patients who achieve long-term disease control have a distinct immune system profile that differs from patients with active disease and from that of healthy adults.

This distinct profile, the researchers argue, likely plays a role in the patients achieving long-term control of their myeloma, and thus deserves further investigation.

The majority of multiple myeloma patients relapse within a median of three years from their initial diagnosis. However, …

This past May, I was traveling on a flight from Calgary to Victoria, British Columbia, to attend a seminar in needle arts, which is a passion in my life.  I have been taking classes and doing projects in embroidery since 2001.

The flight was delayed. When we finally boarded, I and all the other passengers found that the aircraft had been switched from a jet plane to a Dash-8, a smaller propeller-type plane.  My seat assignment was still the same number, but I was now in a row by an emergency exit …